Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 9, 2023heparin 7500 units added to 0.9% sodium chloride 1000mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0981-2023Class IITerminatedAug 9, 2023Neonatal TPN Starter BagLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0980-2023Class IITerminatedAug 9, 2023heparin 5000 units/500mL added to 0.9% sodium chlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0979-2023Class IITerminatedAug 9, 2023heparin 4000 units/1000mL added to 0.9% sodium chlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0978-2023Class IITerminatedAug 9, 2023heparin 2500 units/500mL added to 0.9% sodium chloride 5 units/mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0977-2023Class IITerminatedAug 9, 2023oxyTOCIN 20 units added to 0.9% sodium chloride 1Lack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0976-2023Class IITerminatedAug 9, 2023oxyTOCIN 15 units added to Lactated Ringer's 250 mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0975-2023Class IITerminatedAug 9, 2023heparin 2500 units added to 0.9% sodium chloride 250mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0974-2023Class IITerminatedAug 9, 2023oxyTOCIN 15 units added to 0.9% sodium chloride 250 mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0973-2023Class IITerminatedAug 9, 2023oxyTOCIN 10 units added to Lactated Ringer's 500 mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0972-2023Class IITerminatedAug 9, 2023vancomycin 750 mg/250 mL added to 0.9% Sodium ChlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0971-2023Class IITerminatedAug 9, 2023vancomycin 2 g/500 mL added to 0.9% Sodium ChlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0970-2023Class IITerminatedAug 9, 2023vancomycin 1.75g added to 0.9% sodium chloride 500mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0969-2023Class IITerminatedAug 9, 2023vancomycin 1.5 g/250mL added to 5% dextroseLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0968-2023Class IITerminatedAug 9, 2023vancomycin 1.5 g/500 mL added to 0.9% sodium chlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0967-2023Class IITerminatedAug 9, 2023vancomycin 1.5 g/250 mL added to 0.9% sodium chlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0966-2023Class IITerminatedAug 9, 2023PHENYLephrine 1Lack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0965-2023Class IITerminatedAug 9, 2023phenylephrine 50 mg added to 0.9% sodium chloride 250mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0964-2023Class IITerminatedAug 9, 2023PHENYLephrineLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0963-2023Class IITerminatedAug 9, 2023phenylephrineLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0962-2023Class IITerminatedAug 9, 2023PHENYLephrine 20mg/250ml added to 0.9% sodium chlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0961-2023Class IITerminatedAug 9, 2023PHENYLephrineLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0960-2023Class IITerminatedAug 9, 2023EPINEPHrine 8mg/250ml added to dextrose 5%Lack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0959-2023Class IITerminatedAug 9, 2023EPINEPHrine added to dextrose 5%Lack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0958-2023Class IITerminatedAug 9, 2023EPINEPHrineLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0957-2023Class IITerminatedAug 9, 2023Cardioplegia Solution del Nido FormulaLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0956-2023Class IITerminatedAug 9, 2023vancomycin 1.25 g/250 mL added to 0.9% Sodium ChlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0955-2023Class IITerminatedAug 9, 2023EPINEPHrine 4mg/250mL added to 0.9% sodium chlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0954-2023Class IITerminatedAug 9, 2023dilTIAZem 125mg/125mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0953-2023Class IITerminatedAug 9, 2023glycopyrrolate 1 mg/5 mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0952-2023Class IITerminatedAug 9, 2023dilTIAZem 125mg/125mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0951-2023Class IITerminatedAug 9, 2023vancomycin 1.25 g/250 mL added to dextrose 5%Lack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0950-2023Class IITerminatedAug 9, 2023succinylcholine 200 mg/10 mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0949-2023Class IITerminatedAug 9, 2023vancomycin 1 g/250 mL added to 0.9% sodium chlorideLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0948-2023Class IITerminatedAug 9, 2023rocuronium50 mg/5 mLLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-0947-2023Class IICompletedAug 9, 2023Cromolyn Sodium Oral SolutionCGMP deviation: product released prior to supplier approval.The Ritedose Corporation · D-0946-2023Class IITerminatedAug 2, 2023FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL BagcGMP deviations: due to shipment of rejected units.SCA Pharmaceuticals · D-0945-2023Class IIOngoingAug 2, 2023Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in cottonseed oilLack of Assurance of SterilityNew Vitalis Pharmacy LLC dba New Vitalis Pharmacy · D-0944-2023Class IITerminatedAug 2, 2023Safe Tussin PM Night Time Cough ReliefCGMP Deviations: use of non-food grade lubricant in mixing vessel.Kramer Laboratories, Inc. · D-0943-2023Class IITerminatedAug 2, 2023Safe Tussin DM Cough + Chest CongestionCGMP Deviations: use of non-food grade lubricant in mixing vessel.Kramer Laboratories, Inc. · D-0942-2023